Bimeda News

Bimeda Introduces Enhanced BOVitalize Plus™ Featuring Aspergillus oryzae for Superior Digestive and Nutritional Support

Schaumburg, Illinois— May 12, 2026 — Bimeda is proud to announce the launch of its newly enhanced BOVitalize Plus, now fortified with Aspergillus oryzae (AO) to deliver an even more comprehensive appr...

BIMEDA ANNOUNCES U.S. AVAILABILITY OF GASTROBIM (OMEPRAZOLE) THE FIRST AND ONLY FDA-APPROVED BIOEQUIVALENT TO GASTROGARD (OMEPRAZOLE) FOR EQUINE GASTRIC ULCER TREATMENT

Now available nationwide. Horse owners are encouraged to contact their veterinarian.  Schaumburg, IL — [MAY 5, 2026] — Bimeda® a global leader in animal health solutions, today announced the...

Bimeda® Announces U.S. Launch of Gastrobim™ (Omeprazole) as First and Only FDA-approved Bioequivalent to Gastrogard® (Omeprazole) for Equine Gastric Ulcer Treatment

 Schaumburg, IL — [APR 6, 2026] — Bimeda®, a global leader in animal health solutions, announced today plans for their U.S. launch of GastrobimTM (omeprazole), the first and only FDA-approved bio...

Bimeda® Launches Eprimectin™ Pour-On (eprinomectin): A Cost-Effective Solution for Beef and Dairy Producers

Schaumburg, Illinois (February 9, 2026) – Bimeda®, the No Suits, Just Boots affordable, no-nonsense animal health solutions manufacturer trusted by producers worldwide, proudly announces the launch of...

Bimeda® US Expands SecureCattle® Product Line with New 50‑Dose (250mL) Size

Schaumburg, Illinois (January 8, 2026) – Bimeda US, a global leader in animal health solutions, is pleased to announce the launch of a new 250 mL (50‑dose) size of SecureCattle, giving producers a mor...

Bimeda Welcomes Gene Klaft

We are pleased to announce the appointment of Gene Klaft as Territory Manager for the states of Idaho, Washington and Northern Oregon. Gene will be an integral part of US Cattle Sales team. Gene bring...

Bimeda US Launches Gamrozyne (gamithromycin) - First Bioequivalent to Zactran (gamithromycin)

 Schaumburg, Illinois – Bimeda® US proudly announces the launch of GamrozyneTM, the first and only bioequivalent to Zactran® (Boehringer-Ingelheim®). This milestone expands Bimeda's robust antibi...

Bimeda Welcomes Eric Moore as Director of US Technical Services

We are pleased to announce that Dr. Eric Moore has joined Bimeda as Director of US Technical Services, supporting our Commercial team. Eric brings more than 30 years of leadership and veterinary indus...

Bimeda® US Launches Doracide™ (doramectin topical solution)

Schaumburg, Illinois (May 19, 2025) – Bimeda is pleased to announce the expansion of its anti-parasitic portfolio with the addition of Doracide. Doracide is bioequivalent to Dectomax® Pour-On (Zoetis®...

Bimeda® US Launches SecureCattle® bovine appeasing pheromone analog

Schaumburg, Illinois (APRIL 14, 2025) – Bimeda is pleased to announce an expansion to its product portfolio with the addition of SecureCattle, an analog of the naturally secreted bovine appeasing pher...